Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Over The Counter 20 March 2023: The Shape Of The Global OTC Market To Come, With IQVIA Consumer Health's Amit Shukla
In this episode, HBW Insight catches up with IQVIA Consumer Health’s vice president of global consulting services, Amit Shukla, to find out how the global consumer healthcare market is performing as it comes out of the pandemic. It’s good news, Shukla reveals, based on the firm’s latest intelligence. The market grew double digits in 2022 and is predicted to expand by 5-6% per year in the future - even faster if some of the innovative switches currently in the pipeline succeed. Shukla points to artificial intelligence, sustainability and popular wellness ingredients as trends to watch that will drive future market growth.
‘The Party Is Over': Green Claims Requirements Among Many Regulatory Changes Coming To EU Cosmetics
Biorius CEO Frédéric Lebreux provided updates on EU Green Deal initiatives including revision of the Cosmetic Products Regulation, as well as regulations in development for green claims and ecodesign, at the Independent Beauty Association’s virtual Technical/Regulatory Forum.
Over The Counter 6 March 2023: A Guide To Post-Pandemic Consumer Healthcare Marketing, With Kaizo’s Kerry Lennox
In this episode, HBW Insight speaks to UK PR firm Kaizo’s associate director Kerry Lennox about consumer healthcare marketing in the post-pandemic context. With consumers bombarded by healthcare messaging and increasingly anxious about their health and wellness, Lennox explains how OTC firms can play a key role in supporting responsible self-care. As trust shifts away from governments and scientific experts towards front-line healthcare professionals like pharmacists, OTC brands are becoming more important to consumers, helping them “tune back in” to science-based health and wellness while supporting this crucial part of the healthcare ecosystem.
Givaudan Strikes Deal For Amyris Ingredients, Long-Term Partnership
The deal has Amyris selling three key cosmetic ingredients to Givaudan and producing more biotech ingredients for the Swiss firm over the long term. “In the future, we will continue to push the boundaries of biotech, creating new sustainable innovations for a better beauty future,” says Givaudan’s Maurizio Volpi, president, Fragrance and Beauty.
Sen. Murray ‘Watching Closely’ For US FDA To Implement, Enforce Cosmetics Regulatory Reform
Senate HELP chair Patty Murray says she will ensure FDA implements cosmetics reform correctly and “effectively” uses enforcement tools. EWG exec says previous standards didn’t address “chronic harm caused by a known carcinogen like benzene.”
Group Of European Firms Say EC’s Proposed Ban On Microplastics In Cosmetics Not ‘Far Or Fast Enough’
Firms removing microplastics from cosmetic products maintain European Commission’s deadline for removal across the sector is too generous. Weleda contends nine of 10 personal care products contain microplastics and 7 kg plastics a minute flushed into environment from cosmetics.
PCPC Senior Leaders Discuss Historic 2022 And What’s To Come In New Cosmetics Regulatory Era
HBW Insight spoke with the Personal Care Products Council’s Karin Ross, executive VP of government affairs, and Tom Myers, executive vice president for legal and regulatory affairs and general counsel, to discuss the Modernization of Cosmetic Regulations Act and PCPC’s role to support members’ compliance going forward.
Fragrance Creators Association: Risk-Based Assessments For Ingredients Aren't Broken
With cosmetics industry readying to confront wave of hazard-based regulations in Europe, Fragrance Creators Association publishes white paper to shore up advocacy efforts supporting risk-based assessments.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.